{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:26:25Z","timestamp":1789453585855,"version":"build-2803163510"},"reference-count":33,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Drug and Alcohol Abuse"],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.3109\/00952990.2013.804525","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T16:04:41Z","timestamp":1372435481000},"page":"235-240","source":"Crossref","is-referenced-by-count":30,"title":["QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study"],"prefix":"10.3109","volume":"39","author":[{"given":"Ayman","family":"Fareed","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Emory University, School of Medicine\rAtlanta, GAUSA"},{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedevi","family":"Vayalapalli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Emory University, School of Medicine\rAtlanta, GAUSA"},{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Scheinberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Emory University, School of Medicine\rAtlanta, GAUSA"},{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Gale","sequence":"additional","affiliation":[{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Casarella","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Emory University, School of Medicine\rAtlanta, GAUSA"},{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Drexler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Emory University, School of Medicine\rAtlanta, GAUSA"},{"name":"Atlanta VA Medical Center\rDecatur, GAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090080008002"},{"key":"CIT0002","first-page":"2011","volume":"66","author":"Dole VP","year":"1966","journal-title":"N Y State J Med"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-6-200209170-00010"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.11.003"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2469"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2006.10400590"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00205-7"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1159\/000081416"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.100180"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.06.012"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.11.055"},{"key":"CIT0012","unstructured":"Committee for Proprietary Medicinal Products. Points to Consider: The Assessment of the Potential for QT Interval Prolongation by Non-Cardiovascular Medicinal Products. vol. CPMP 986\/96. London: The European Agency for the Evaluation of Medicinal Products; 1997"},{"key":"CIT0013","volume-title":"Guidance for Industry: E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"U.S. Food and Drug Administration","year":"2005"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02337-8"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01668.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.802.32186"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-6-200209170-00010"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1280"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00237.x"},{"key":"CIT0021","first-page":"2940","volume":"124","author":"Krook AL","year":"2004","journal-title":"Tidsskr Nor Laegeforen"},{"key":"CIT0022","unstructured":"MEDSAFE. Cardiac vigilance recommended for methadone: New Zealand medicines and medical devices safety authority. Prescriber Update 2, 23\u201325. 2005. Ref Type: Generic"},{"key":"CIT0023","volume-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"DH","year":"2007"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903436044"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2010.58.4.338"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038240"},{"key":"CIT0027","first-page":"220","volume":"299","author":"Ferreira S","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440140080036"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030405011"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.10.1301"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.5.797"},{"key":"CIT0032","doi-asserted-by":"crossref","unstructured":"Stallvik M, Nordstrand B, Kristensen O, Bathen J, Skogvoll E, Spigset O. Corrected QT interval during treatment with methadone and buprenorphine - relation to doses and serum concentrations. Drug Alcohol Depend 2013;129:88-93","DOI":"10.1016\/j.drugalcdep.2012.09.016"},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Fareed A, Byrd-Sellers J, Vayalapalli S, Drexler K, Phillips LS. Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment. Am J Addict (in press). DOI: 10.1111\/j.1521-0391.2013.12043.x","DOI":"10.1111\/j.1521-0391.2013.12043.x"}],"container-title":["The American Journal of Drug and Alcohol Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/00952990.2013.804525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:46:40Z","timestamp":1596847600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/00952990.2013.804525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7,1]]}},"alternative-id":["10.3109\/00952990.2013.804525"],"URL":"https:\/\/doi.org\/10.3109\/00952990.2013.804525","relation":{},"ISSN":["0095-2990","1097-9891"],"issn-type":[{"value":"0095-2990","type":"print"},{"value":"1097-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}